
ACHC Valuation
Acadia Healthcare Company Inc
- Overview
- Forecast
- Valuation
- Earnings
ACHC Relative Valuation
ACHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ACHC is overvalued; if below, it's undervalued.
Historical Valuation
Acadia Healthcare Company Inc (ACHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.70 is considered Undervalued compared with the five-year average of 19.48. The fair price of Acadia Healthcare Company Inc (ACHC) is between 72.29 to 91.94 according to relative valuation methord. Compared to the current price of 22.11 USD , Acadia Healthcare Company Inc is Undervalued By 69.41%.
Relative Value
Fair Zone
72.29-91.94
Current Price:22.11
69.41%
Undervalued
8.48
PE
1Y
3Y
5Y
Trailing
Forward
6.31
EV/EBITDA
Acadia Healthcare Company Inc. (ACHC) has a current EV/EBITDA of 6.31. The 5-year average EV/EBITDA is 11.52. The thresholds are as follows: Strongly Undervalued below 6.77, Undervalued between 6.77 and 9.15, Fairly Valued between 13.89 and 9.15, Overvalued between 13.89 and 16.27, and Strongly Overvalued above 16.27. The current Forward EV/EBITDA of 6.31 falls within the Strongly Undervalued range.
8.73
EV/EBIT
Acadia Healthcare Company Inc. (ACHC) has a current EV/EBIT of 8.73. The 5-year average EV/EBIT is 14.89. The thresholds are as follows: Strongly Undervalued below 8.93, Undervalued between 8.93 and 11.91, Fairly Valued between 17.87 and 11.91, Overvalued between 17.87 and 20.85, and Strongly Overvalued above 20.85. The current Forward EV/EBIT of 8.73 falls within the Strongly Undervalued range.
0.60
PS
Acadia Healthcare Company Inc. (ACHC) has a current PS of 0.60. The 5-year average PS is 1.96. The thresholds are as follows: Strongly Undervalued below 0.71, Undervalued between 0.71 and 1.33, Fairly Valued between 2.59 and 1.33, Overvalued between 2.59 and 3.22, and Strongly Overvalued above 3.22. The current Forward PS of 0.60 falls within the Strongly Undervalued range.
4.10
P/OCF
Acadia Healthcare Company Inc. (ACHC) has a current P/OCF of 4.10. The 5-year average P/OCF is 16.14. The thresholds are as follows: Strongly Undervalued below -5.52, Undervalued between -5.52 and 5.31, Fairly Valued between 26.96 and 5.31, Overvalued between 26.96 and 37.79, and Strongly Overvalued above 37.79. The current Forward P/OCF of 4.10 falls within the Undervalued range.
-22.10
P/FCF
Acadia Healthcare Company Inc. (ACHC) has a current P/FCF of -22.10. The 5-year average P/FCF is -23.98. The thresholds are as follows: Strongly Undervalued below -641.99, Undervalued between -641.99 and -332.98, Fairly Valued between 285.02 and -332.98, Overvalued between 285.02 and 594.03, and Strongly Overvalued above 594.03. The current Forward P/FCF of -22.10 falls within the Historic Trend Line -Fairly Valued range.
Acadia Healthcare Company Inc (ACHC) has a current Price-to-Book (P/B) ratio of 0.66. Compared to its 3-year average P/B ratio of 2.02 , the current P/B ratio is approximately -67.44% higher. Relative to its 5-year average P/B ratio of 2.08, the current P/B ratio is about -68.34% higher. Acadia Healthcare Company Inc (ACHC) has a Forward Free Cash Flow (FCF) yield of approximately -15.02%. Compared to its 3-year average FCF yield of -4.91%, the current FCF yield is approximately 206.26% lower. Relative to its 5-year average FCF yield of -0.41% , the current FCF yield is about 3553.87% lower.
0.64
P/B
Median3y
2.02
Median5y
2.08
-15.21
FCF Yield
Median3y
-4.91
Median5y
-0.41
Competitors Valuation Multiple
The average P/S ratio for ACHC's competitors is 1.21, providing a benchmark for relative valuation. Acadia Healthcare Company Inc Corp (ACHC) exhibits a P/S ratio of 0.60, which is -50.80% above the industry average. Given its robust revenue growth of 9.19%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ACHC decreased by 73.70% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 796.04M to 869.23M.
The secondary factor is the P/E Change, contributed -25.85%to the performance.
Overall, the performance of ACHC in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

SR
Spire Inc
76.560
USD
0.00%

GVA
Granite Construction Inc
110.500
USD
+0.78%

SIM
Grupo Simec SAB de CV
27.960
USD
0.00%

ORA
Ormat Technologies Inc
91.580
USD
-1.15%

SRRK
Scholar Rock Holding Corp
33.780
USD
+1.35%

BCO
Brinks Co
111.840
USD
-0.20%

BTDR
Bitdeer Technologies Group
12.950
USD
-1.30%

RXO
RXO Inc
16.190
USD
-0.18%

SMG
Scotts Miracle-Gro Co
62.230
USD
+0.26%

OGN
Organon & Co
9.070
USD
+0.11%
FAQ

Is Acadia Healthcare Company Inc (ACHC) currently overvalued or undervalued?
Acadia Healthcare Company Inc (ACHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 8.70 is considered Undervalued compared with the five-year average of 19.48. The fair price of Acadia Healthcare Company Inc (ACHC) is between 72.29 to 91.94 according to relative valuation methord. Compared to the current price of 22.11 USD , Acadia Healthcare Company Inc is Undervalued By 69.41% .

What is Acadia Healthcare Company Inc (ACHC) fair value?

How does ACHC's valuation metrics compare to the industry average?

What is the current P/B ratio for Acadia Healthcare Company Inc (ACHC) as of Aug 27 2025?

What is the current FCF Yield for Acadia Healthcare Company Inc (ACHC) as of Aug 27 2025?

What is the current Forward P/E ratio for Acadia Healthcare Company Inc (ACHC) as of Aug 27 2025?
